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Introduction
Legal highs is the common term for a collection of drugs, many of which are new, or are older drugs, now misused [1, 2] . There is debate around nomenclature and definition [3] , but within Europe most researchers use the term novel psychoactive substance (NPS), using the definition of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) [4] .
Over the last 5-10 years there has been a steady increase in the number of NPS [5] with approximately 100 new NPS found in 2013. There are also increasing numbers of deaths associated with legal high use [6] , although in most cases the deceased are polydrug misusers and the drug(s) which caused death cannot be accurately determined. Despite this, and the increased media attention, many healthcare professionals know little about NPS, and there are few studies describing their pharmacology or toxicity, mephedrone being a notable exception. With anticipated increases in NPS use and consequent public health issues, there is a need to educate healthcare professionals about NPS.
In the UK, the Pharmacy profession is moving towards a more front-line position, where patients may come to see a pharmacist about a problem instead of visiting their general practitioner (GP). It is anticipated that this will increasingly become the case with a predicted reduction in UK GP services, and prescribing pharmacists becoming more common. The role of the pharmacists in prescription drug misuse is acknowledged [7] . Despite this, the Pharmacy curriculum, at least in the UK, does not typically place much emphasis on drug misuse and almost nothing is taught regarding NPS. The UK General Pharmaceutical
Council, in its 2011 'Future Pharmacists' [8] document briefly mentions drug misuse, but
there is no mention of NPS. Thus, education on substance use and misuse targeting pharmacists and the pharmacy team is very limited. Two optional short courses 'Substance use and misuse' and 'Addiction, misuse and dependency' have been developed by the Centre for Pharmacy Postgraduate Education (CPPE) in order to prevent the misuse of overthe-counter (OTC), prescription medicines and traditional drugs of abuse such as cocaine and heroin. These courses aim to equip pharmacists to identify groups of patients who may misuse OTC or prescription medicines and learn about the pharmaceutical interventions that could be undertaken. These courses do not include information on NPS [9] [10] . 3 We can thus foresee a time in the near future where more and more pharmacists will be asked about NPS by their patients, with pharmacists not having appropriate knowledge to answer them. This pilot study was designed to gauge UK pharmacists' knowledge of NPS with a view to designing appropriate educational resources for pharmacists and related healthcare professionals. 4 
Methods
Questionnaire. The survey was based on an existing questionnaire used for a previous EUfunded project (RedNet; http://www.rednetproject.eu) and contained a brief definition of NPS and the categories used by the EMCDDA. The survey first asked for some demographic data (e.g. sex, age, years of pharmacy practise) then asked about knowledge of NPS. We then listed 38 relatively well known NPS and asked subjects if they had heard of them.
Finally we asked about what type of information they would like about NPS and whether it was important to their pharmacy practice. Statistics. Data were collated and graphed using SigmaPlot. Spearman correlation analysis was performed on age of pharmacist versus number of NPS of which they were aware. 
Results
Participants. Of the 54 respondents there were 32 female (59%) and 22 male (41%). Most considered that they had 'poor' to 'basic' knowledge of NPS (40 pharmacists; 74%; Fig 1A) and most (29; 54%) did not provide advice or counselling to patients or customers on NPS, while only 8 (15%) said that they did provide counselling on NPS ( Fig 1B) .
Knowledge of NPS.
Of 36 relatively common NPS we listed, 16 (30%) pharmacists were not aware that any were being misused, while 11 (20%) were only aware that 1 was being misused ( Fig 1C) . The most commonly recognised misused drugs were pregabalin (recognised by 32 pharmacists; 59%), mephedrone (17; 31%), benzydamine (13; 25%), tropicamide (9; 18%) and 'Spice' (9; 18%). There was a negative correlation between the age of the pharmacist and the number of NPS that they had heard of (p < 0.01, Pearson's correlation; Fig 1D) .
Relevance of NPS to Pharmacy and future learning needs. Although 20 pharmacists (20; 37%) thought that knowledge of NPS had 'little' significance to their work ( Fig 1E) , the overwhelming majority (50; 93%) thought that they did not have enough information about NPS. Most got their information from the internet/web (21, 39%), followed by the media (15; 28%), seminars (12; 22%) and email (11; 20%; Fig 1F) . The majority wanted to be updated about NPS (44; 81%) with only 8 (15%) stating that they did not want to be updated. Their preferred method for being updated was by email (38; 70%), followed by the Internet/Web (25; 46%) and online courses (19; 35%).
When asked about the type of information that they wanted, to improve their knowledge of NPS, it was found that knowledge of NPS adverse events, clinical warnings and desired psychoactive effects were considered most significant, all 3 were rated higher compared to knowledge of chemical characterisation of NPS (H (12) =24.04, P < 0.05; Fig 2) . 6 
Discussion
These pilot data suggest that although knowledge of NPS may not have been considered central to a pharmacist's job, with few pharmacists offering advice on NPS to customers or patients, there is an acknowledgement that information on this area is needed.
Of the 36 relatively common NPS listed in the survey, pregabalin was the most well-known misused drug. This is unsurprising as it is prescribed for neuropathic pain, anxiety and epilepsy, is misused [11] and is increasingly associated with drug-related deaths [6] . Of the other well-recognised NPS, benzydamine is found in oral rinses for sore throats and tropicamide is used to dilate the pupil in diagnostic eye test; both these drugs are misused [12, 13] . Thus the number of genuinely 'novel' psychoactive substance known by pharmacists is small, with the stimulant mephedrone and the synthetic cannabinoid 'Spice' drugs the best known. This confirms that pharmacists in London have a poor knowledge of NPS.
The re-emergence and abuse of older clinically used/tested drugs is not a new phenomenon, but appears to be gathering pace. There are increasing numbers of old disused clinical drugs being rebranded by Internet opportunists as legal highs. For example, desoxypipradrol, tested for narcolepsy many decades ago, resurfaced in 2009 as 'Ivory Wave' and was associated with a number of drug related deaths [14] . In addition, alphamethyltryptamine (AMT), once used as an antidepressant, is also now misused [15] and associated with drug-related deaths [6] . It should be noted that in most cases the exact cause of death is not known because multiple drugs, including alcohol and nicotine, are typically taken by drug misusers. The multiple online user forums are full of user reports specifying which drug combinations have been taken to obtain the psychological changes sought, and also drug(s) taken to ease the comedown, facilitate sleep or reduce withdrawal effects.
In the UK, pharmacists are leading health care professionals in the different health care settings. In primary care, it was reported that more than 1.4 million people visit 11,500 community pharmacies on the high streets every day in England. This makes pharmacists 7 very well suited to reach out to customers or patients who may have or may be developing substance misuse [16] . Pharmacists are equipped with the knowledge and skills to promote education, detection, prevention and treatment of drug misuse [17] . In 2010, pharmacists were formally notified of the health harms related to a new 'legal high' called 'Ivory Wave'.
With the limited knowledge provided then, pharmacists were able to raise awareness and educate customers on the potential toxicities that may result from the intake of this substance [18] . This study has some limitations. The sample is a self-selected one drawn from registered pharmacists working in community pharmacies in North West London, and thus does not include hospital pharmacies. Self-selection means that respondents may only reflect those who are interested in the NPS phenomenon and not the wider pharmacy community. The geographical area covered may not be representative of London as a whole, or indeed other parts of the UK or other EU countries. Despite this, it is clear that London pharmacists do not know much about NPS but would like to know more. 
Within their profession, pharmacists are involved in the provision

Conclusions
In conclusion, pharmacy education involving knowledge on NPS health harms, potential pharmaceutical interventions and referral pathways is lacking. Education related to NPS
